LOS ANGELES, Nov. 12, 2014 /PRNewswire/ -- Migranade. inc. announced today the new migraine medication, MIGRANADE Migraine Relief, will soon be available to migraine sufferers around the globe. Migranade,Inc., the maker of the new homeopathic drug, says it has begun an out-licensing program that allows companies to obtain the exclusive distribution rights for the new medicine for specific international territories.
The medicine was developed from a platform technology that targets the actual cause of migraines and not just the symptoms. In the U.S., MIGRANADE Migraine Relief is available at www.migranade.com and will soon hit the major retail chains.
Companies interested in obtaining a distribution license for MIGRANADE Migraine Relief should contact the licensing department at [email protected].
ABOUT MIGRANADE MIGRAINE RELIEF
MIGRANADE Migraine Relief (www.migranade.com) is an oral effervescent homeopathic medication for the treatment of migraine headaches. MIGRANADE Migraine Relief is designed to target the actual cause of the migraine headaches vs. only treating symptoms.
ABOUT MIGRANADE, INC.
Migranade, Inc. (www.migranadeinc.com) is a U.S. based pharmaceutical company with a focus on the research and development, manufacturing and marketing of medications for the treatment and prevention of migraine headache. The Company has OTC, prescription and medical device divisions. For media inquiries contact Orange County, CA Public Relations Agency www.drivenpublicrelations.com or send an email to [email protected].
Contact: Natasha Nelson, Driven Public Relations, 949-280-9705, [email protected]
SOURCE Migranade, Inc.